Stay updated with breaking news from Eye Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DBMR have recently added a report titled ‘Global Legal Marijuana Market Size, Share, Growth, Industry Trends and Forecast to 2028’ Report to our extensive database of reports. Our team of experts has curated the report by considering industry-relevant information related to the leading vendors, distributors, and ser...
The Latest released survey report on Global Ophthalmology Drugs and Devices Market aims to deliver an in-depth outline regarding the trends and market development scenario to outpace market with relevant strategies. This also report provide the details about industry overview and analysis about size, share, growth,...
Retinal Disorder Treatment Market Research Report by Type, by Dosage Form, by Distribution Channel - United States Forecast to 2025 - Cumulative Impact of COVID-19 Retinal Disorder Treatment Market Research Report by Type (Diabetic Retinopathy and Macular Degeneration), by Dosage Form (Capsules & Tablets, Eye Drops, Eye Solutions, Gels, and Ointments), by Distribution Channel - United States Forecast to 2025 - Cumulative Impact of COVID-19 May 10, 2021 08:59 ET | Source: ReportLinker ReportLinker Lyon, FRANCE New York, May 10, 2021 (GLOBE NEWSWIR...
Share this article Share this article ResearchAndMarkets.com's offering. The global ophthalmic drugs market size is expected to reach USD 60.3 billion by 2028. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. An increase in the prevalence of eye-related disorders, such as presbyopia, macular degeneration, and diabetic retinopathy, is one of the major drivers of the market. According to the American Academy of Ophthalmology, over 2.71 million people in the U.S. were affected by Primary Open-angle Glaucoma (POAG) in 2011, and the number is estimated to reach 7.3 million b...
expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. An increase in the prevalence of eye-related disorders, such as presbyopia, macular degeneration, and diabetic retinopathy, is one of the major drivers of the market. According to the American Academy of Ophthalmology, over 2.71 million people in the U.S. were affected by Primary Open-angle Glaucoma (POAG) in 2011, and the number is estimated to reach 7.3 million by 2050. Key suggestions from the report: In 2020, anti-VEGF...